本页面由Tiger Trade Technology Pte. Ltd.提供服务

Humacyte, Inc.

0.3589
-0.0307-7.88%
盘后:0.36640.0075+2.09%17:37 EDT
成交量:1,232.40万
成交额:457.22万
市值:9,977.42万
市盈率:-0.72
高:0.3908
开:0.3896
低:0.3555
收:0.3896
52周最高:1.90
52周最低:0.3555
股本:2.78亿
流通股本:2.45亿
量比:1.60
换手率:5.03%
股息:- -
股息率:- -
每股收益(TTM):-0.4975
每股收益(LYR):-0.2582
净资产收益率:-547.87%
总资产收益率:-49.87%
市净率:3.19
市盈率(LYR):-1.39

数据加载中...

2024/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/07

SEC问询函

Form CORRESP - Correspondence
2024/07/31

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]